Table 3. Reactivation Kinetics of hAChE Inhibited by Nerve Agent Surrogated and Paraoxon by Selected Oximesa.
| OP | oxime | kr min–1 | KD mM | kr2 mM–1·min–1 |
|---|---|---|---|---|
| NEMP | 1 | 0.4 ± 0.1 | 4 ± 1 | 0.1 |
| 2 | 0.3 ± 0.01 | 1 ± 0.09 | 0.2 | |
| 3 | 0.5 ± 0.07 | 1.5 ± 0.3 | 0.3 | |
| 4 | 1 ± 0.1 | 1 ± 0.3 | 1 | |
| 4’ | 1 ± 0.02 | 1 ± 0.04 | 1 | |
| 5 | 2.5 ± 0.2 | 2.4 ± 0.4 | 1.0 | |
| HI-6 | 0.65 ± 0.03 | 0.07 ± 0.008 | 9.3 | |
| 2-PAM | 0.1 ± 0.01 | 0.2 ± 0.06 | 0.5 | |
| obidoxime | 0.2 ± 0.007 | 0.6 ± 0.04 | 0.3 | |
| NIMP | 1 | 0.2 ± 0.006 | 1 ± 0.08 | 0.2 |
| 2 | 0.2 ± 0.02 | 2 ± 0.4 | 0.1 | |
| 3 | 0.2 ± 0.01 | 1.3 ± 0.2 | 0.15 | |
| 4 | 0.7 ± 0.1 | 2 ± 0.5 | 0.4 | |
| 4’ | 0.4 ± 0.09 | 2 ± 0.7 | 0.2 | |
| 5 | nd | nd | 0.2 | |
| HI-6 | 1 ± 0.2 | 0.09 ± 0.03 | 11 | |
| 2-PAM | 0.24 ± 0.02 | 0.2 ± 0.03 | 1.2 | |
| obidoxime | 0.2 ± 0.02 | 0.5 ± 0.09 | 0.4 | |
| NEDPA | 1 | 0.1 ± 0.01 | 1.3 ± 0.2 | 0.1 |
| 2 | 0.2 ± 0.02 | 1.2 ± 0.3 | 0.2 | |
| 3 | 0.2 ± 0.08 | 3 ± 1.4 | 0.07 | |
| 4 | 0.6 ± 0.02 | 0.9 ± 0.1 | 0.6 | |
| 4’ | 0.5 ± 0.04 | 0.6 ± 0.1 | 0.8 | |
| 5 | 0.8 ± 0.2 | 3 ± 1 | 0.3 | |
| HI-6 | 0.05 ± 0.005 | 0.2 ± 0.04 | 0.2 | |
| 2-PAM | 0.15 ± 0.025 | 0.8 ± 0.2 | 0.2 | |
| obidoxime | 0.6 ± 0.04 | 0.3 ± 0.07 | 2 | |
| PARAOXON | 1 | 0.03 ± 0.005 | 0.5 ± 0.2 | 0.05 |
| 2 | nd | nd | 0.2 | |
| 3 | 0.2 ± 0.08 | 2 ± 0.4 | 0.2 | |
| 4 | 0.6 ± 0.1 | 2 ± 0.7 | 0.3 | |
| 4’ | nd | nd | 0.8 | |
| 5 | 0.6 ± 0.1 | 2.7 ± 0.7 | 0.2 | |
| HI-6 | 0.09 ± 0.009 | 0.8 ± 0.14 | 0.1 | |
| 2-PAM | 0.05 ± 0.006 | 0.4 ± 0.08 | 0.1 | |
| obidoxime | 0.3 ± 0.02 | 0.5 ± 0.09 | 0.6 |
nd: If [reactivator] ≪ KD, then there is a linear dependence between kobs and [reactivator]: kobs = (kr/KD)[reactivator]. In this case, kr and KD cannot be determined, but kr2 = kr/KD is the slope of the line and can be directly obtained by fitting.